Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.
Emilio Bajetta(Fondazione Lanza), Irene Floriani(Mario Negri Institute for Pharmacological Research), Stefano Cordio(Ospedale San Carlo), A. Ciarlo, Francesco Di Costanzo, Francesca Di Fabio(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), G. Rosati(Azienda Ospedaliera di Cosenza), Ermanno Rondini(Santa Maria Nuova Hospital), Anna Maria Bochicchio(Ospedale San Carlo), Lorenza Landi(Tumori Foundation), R. Casaretti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Di Bartolomeo(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrea Mambrini, Roberto Labianca(Ospedale Papa Giovanni XXIII), Giovanni Luca Frassineti, Paolo Bidoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Armando Santoro(IRCCS Humanitas Research Hospital), Sergio Ricci(St Bartholomew's Hospital), E. Pasquini(Ospedale Infermi di Rimini), Graziella Pinotti(Medica (Italy))
Cited by 15
Related Papers
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
|Journal of Clinical Oncology|2005|1.9k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
|The Lancet|2009|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k